SCHEMBL722813

SCHEMBL722813

C=CC(C)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6039939 0.77
SCHEMBL614363 0.77
SCHEMBL8147302 0.77
SCHEMBL3613625 0.77
SCHEMBL9410982 0.77
SCHEMBL16566061 0.76
SCHEMBL4937711 0.76 GRIK1 (0.32)
SCHEMBL4937710 0.76 GRIK1 (0.32)
SCHEMBL4937720 0.76 GRIK1 (0.32)
SCHEMBL6728798 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11964060-B2 Nicotine-containing transparent transdermal therapeutic system LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2024-04-23 US disclosed
US-20200230074-A1 NICOTINE-CONTAINING TRANSPARENT TRANSDERMAL THERAPEUTIC SYSTEM LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2020-07-23 US disclosed
CN-110325216-A Transparent transdermal therapeutic system containing nicotine LTS勒曼治疗系统股份公司 2019-10-11 CN disclosed
US-20150191607-A1 Anti-fouling Paints and Coatings REACTIVE SURFACES, LTD (US) 2015-07-09 US disclosed
EP-2794785-A1 INKJET INK COMPOSITION Eastman Kodak Company (US) 2014-10-29 EP disclosed
US-20140196631-A1 VISUAL ASSAYS FOR COATINGS INCORPORATING BIOACTIVE ENZYMES FOR CATALYTIC FUNCTIONS REACTIVE SURFACE, LTD. (US) 2014-07-17 US disclosed
WO-2013096048-A1 INKJET INK COMPOSITION EASTMAN KODAK COMPANY (US) 2013-06-27 WO disclosed
WO-2013096389-A1 POLYMER COMPOSITION EASTMAN KODAK COMPANY (US) 2013-06-27 WO disclosed
US-20120097194-A1 Polymeric Coatings Incorporating Bioactive Enzymes for Catalytic Function REACTIVE SURFACES, LTD. (US) 2012-04-26 US disclosed
WO-2012027331-A1 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME AND RELATED DISEASES AND DISORDERS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-03-01 WO disclosed
US-20070270085-A1 CHEMICAL MECHANICAL POLISHING SLURRY, CMP PROCESS AND ELECTRONIC DEVICE PROCESS HITACHI CHEMICAL COMPANY, LTD. (JP) 2007-11-22 US disclosed
WO-2007018376-A1 PRODUCING METHOD FOR CERIUM-BASED GLASS POLISHING MATERIAL AND METHOD FOR USING THE SAME JOUNG IN (KR) 2007-02-15 WO disclosed
EP-1346377-A1 ELECTRICAL CABLE, PARTICULARLY FOR HIGH VOLTAGE DIRECT CURRENT TRANSMISSION OR DISTRIBUTION, AND INSULATING COMPOSITION PIRELLI S.p.A. (IT) 2003-09-24 EP disclosed
WO-2002052582-A1 ELECTRICAL CABLE, PARTICULARLY FOR HIGH VOLTAGE DIRECT CURRENT TRANSMISSION OR DISTRIBUTION, AND INSULATING COMPOSITION PIRELLI S.P.A. (IT) 2002-07-04 WO disclosed
EP-1077683-A1 ANTIDEPRESSANT THERAPY ALZA CORPORATION (US) 2001-02-28 EP disclosed
WO-1999058115-A1 ANTIDEPRESSANT THERAPY ALZA CORPORATION (US) 1999-11-18 WO disclosed
EP-0700289-A1 ANTIDEPRESSANT DOSAGE FORM ALZA CORPORATION (US) 1996-03-13 EP disclosed
WO-1994027589-A2 ANTIDEPRESSANT DOSAGE FORM ALZA CORPORATION (US) 1994-12-08 WO disclosed
EP-0598788-A1 POLYMERIC SCAVENGERS FOR OXIDIZED DEVELOPING AGENTS AND PHOTOGRAPHIC ELEMENTS CONTAINING THE SAME. EASTMAN KODAK CO (US) 1994-06-01 EP disclosed
WO-1993003421-A1 POLYMERIC SCAVENGERS FOR OXIDIZED DEVELOPING AGENTS AND PHOTOGRAPHIC ELEMENTS CONTAINING THE SAME EASTMAN KODAK COMPANY (US) 1993-02-18 WO disclosed